23. Symposium of the AGNP

Abstracts (HTML) List of Authors

van Boemmel, F.

Interferon-alpha treatment and serotonergic dysfunction

van Calker, D.

Adenosinergic mechanisms in the brain: Potential targets for the treatment of mood disorders?
Mechanism of action of mood stabilizers

Varga, A.

Further significance for the diagnostic and therapeutic usefulness of the non oxidative direct ethanol metabolites ethyl glucuronide (EtG), fatty acid ethyl esters (FAEEs) and phosphatidyl ethanol (PEth) in comparison to traditional markers

Vedder, H.

Cytoimmunological changes and treatment response in major depression
Cytokines, the regulation of body weight and psychopharmacological treatment

Vernaleken, I.

Sensitivity of GABAergic systems in male alcoholics and subjects at risk for alcoholism
Pharmacological modulation of dopaminergic systems in neuropsychiatric disorders studied with positron emission tomography

Viviani, R.

Psychopharmacological treatment from the patients’ perspective. A computer-based automatic interview system

Voderholzer, U.

Transient narcolepsy-cataplexy-syndrome after discontinuation of the antidepressant venlafaxine

Vogel, M.

Investigative drug monitoring of antipsychotics and antidepressants during acute admission in a psychiatric state hospital in Germany
Management of the atypical antipsychotic olanzapine (Zyprexa) in a clinical environment with particular regard to therapeutic drug monitoring (TDM) in a German state hospital

Vogel, T.

Toxoplasmosis in schizophrenia, bipolar and depressive disorders versus healthy controls: Immunologic and epidemiologic findings

Volkmann, J.

Comparative study of citalopram and amitriptyline in depression in patients with Parkinson’s disease

von Kleinsorgen, M.

Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P

Vucurevic, G.

Effective connectivity and pharmacological modulation in schizophrenia

v Widdern, O.

CRH1- and GR-gene SNPs and haplotypes: Associations with response to Dex/CRH test and antidepressant treatment?